Literature DB >> 16249231

Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.

R J François1, L Neure, J Sieper, J Braun.   

Abstract

OBJECTIVE: To characterise the immunohistological features of sacroiliitis in ankylosing spondylitis (AS) at different disease stages.
METHODS: Biopsy samples from sacroiliac joints (SIJs) of five patients with AS, two with early, three with advanced changes and samples from age matched controls from one necropsy SIJ and two iliac bone marrow (BM) biopsies were studied. Paraffin sections were immunostained in triplicate for T cells (CD3, CD8), macrophages (CD68), and the cytokines tumour necrosis factor alpha (TNFalpha), interferon gamma, interleukin (IL) 1beta, IL6, IL10, and transforming growth factor beta1 (TGFbeta1). Stained cells were counted over one entire high power field (x400) per section in BM, cartilage, and other connective tissue (CT). Results are the mean of three sections.
RESULTS: CD3+ T cells were numerous in the BM of early AS, and in the CT of one patient with early and one with late AS, with variable proportions of CD8+ T cells. All patients with AS had more CD68+ macrophages than controls in BM and CT; in cartilage, one patient with early and one with late AS had increased CD68+ cells, some being osteoclasts. The patient with very early AS had large numbers of TNFalpha cells in the three tissular areas; for the other patient with early disease they were found only in CT and cartilage. IL6 was seen in 4/4 patients with AS in most areas. Patients with early disease had more T cells, TNFalpha, and IL6, and patients with advanced AS more TGFbeta1.
CONCLUSION: The immunohistological findings of a limited sample suggest a role for BM in sacroiliitis, for TNFalpha and IL6 in early, active lesions, and for TGFbeta1 at the time of secondary cartilage and bone proliferation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249231      PMCID: PMC1798185          DOI: 10.1136/ard.2005.037465

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  50 in total

1.  Clinicopathological conference. A case of early ankylosing spondylitis with fatal secondary amyloidosis.

Authors: 
Journal:  Br Med J       Date:  1968-05-18

2.  Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha.

Authors:  D Baeten; N Van Damme; F Van den Bosch; E Kruithof; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

3.  Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.

Authors:  M Rudwaleit; S Siegert; Z Yin; J Eick; A Thiel; A Radbruch; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

4.  Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis.

Authors:  R J François; D L Gardner; E J Degrave; E G Bywaters
Journal:  Arthritis Rheum       Date:  2000-09

5.  Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.

Authors:  Dominique Baeten; Pieter Demetter; Claude A Cuvelier; Elli Kruithof; Nancy Van Damme; Martine De Vos; Eric M Veys; Filip De Keyser
Journal:  J Pathol       Date:  2002-03       Impact factor: 7.996

6.  Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.

Authors:  J Zou; Y Zhang; A Thiel; M Rudwaleit; S-L Shi; A Radbruch; R Poole; J Braun; J Sieper
Journal:  Rheumatology (Oxford)       Date:  2003-02-28       Impact factor: 7.580

7.  An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis.

Authors:  Heiner Appel; Lucia Neure; Maren Kuhne; Jürgen Braun; Martin Rudwaleit; Joachim Sieper
Journal:  Clin Rheumatol       Date:  2004-07-28       Impact factor: 2.980

8.  Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis.

Authors:  H S Howe; P L Cheung; K O Kong; H Badsha; B Y H Thong; K P Leong; E T Koh; T Y Lian; Y K Cheng; S Lam; D Teo; T C Lau; B P Leung
Journal:  Rheumatology (Oxford)       Date:  2004-10-12       Impact factor: 7.580

9.  Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).

Authors:  A Bucht; P Larsson; L Weisbrot; C Thorne; P Pisa; G Smedegård; E C Keystone; A Grönberg
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

10.  Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis.

Authors:  J Brandt; A Khariouzov; J Listing; H Haibel; H Sörensen; L Grassnickel; M Rudwaleit; J Sieper; J Braun
Journal:  Arthritis Rheum       Date:  2003-06
View more
  52 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 2.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 3.  Mechanisms of pathologic new bone formation.

Authors:  Kurt de Vlam; Rik J U Lories; Frank P Luyten
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

4.  Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis.

Authors:  You-Fan Peng; Qiong Zhang; Ling Cao; Yang Liu; Dan Chen; Yu-Kun Sun; Zhao-Xia Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Effects of high-dose corticosteroids on post-traumatic inflammatory mediators.

Authors:  Olav Reikerås; Arthur Helle; Claus Danckert Krohn; Jens Ivar Brox
Journal:  Inflamm Res       Date:  2009-06-28       Impact factor: 4.575

6.  Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population.

Authors:  Won-Tae Chung; Jung-Yoon Choe; Won Cheoul Jang; Su Min Park; Young Chang Ahn; Il Kyu Yoon; Tae-Hwan Kim; Youn-Hyoung Nam; Sung-Hoon Park; Sung-Won Lee; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2010-03-28       Impact factor: 2.631

7.  Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis.

Authors:  Yong-Gil Kim; Dong Hyun Sohn; Xiaoyan Zhao; Jeremy Sokolove; Tamsin M Lindstrom; Bin Yoo; Chang-Keun Lee; John D Reveille; Joel D Taurog; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

Review 8.  The synovio-entheseal complex in enthesoarthritis.

Authors:  Angelo De Cata; Michele Inglese; Rosa Rubino; Francesca Molinaro; Gianluigi Mazzoccoli
Journal:  Clin Exp Med       Date:  2015-02-12       Impact factor: 3.984

9.  Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.

Authors:  Dongyi He; Qi Zhu; Quan Zhou; Qing Qi; Hongmei Sun; Liza M Zachariah; Grace Wang; John D Reveille; Yongtao Guan; Xiaodong Zhou
Journal:  Clin Rheumatol       Date:  2017-04-22       Impact factor: 2.980

10.  Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

Authors:  Paul A C Lord; Tracey M Farragher; Mark Lunt; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Rheumatology (Oxford)       Date:  2009-12-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.